Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

330.38
Delayed Data
As of Aug 04
 +6.00 / +1.85%
Today’s Change
290.85
Today|||52-Week Range
480.18
-2.67%
Year-to-Date

Today’s Trading

Previous close324.38
Today’s open325.88
Day’s range324.52 - 334.80
Volume3,566,952
Average volume (3 months)1,960,756
Market cap$76.3B
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+15.08%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+39.61%
P/E ratio22.4
Price/Sales8.30
Price/Book7.04

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc+3.95+11.92%
BAXBaxter International...+0.80+2.02%
AMGNAmgen-0.79-0.45%
XONIntrexon Corp+0.14+0.21%
Data as of 4:14pm ET, 08/04/2015

Financials

Next reporting dateOctober 20, 2015
EPS forecast (this quarter)$3.92
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts